Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9910894 | Pathology - Research and Practice | 2005 | 6 Pages |
Abstract
S100A9, a calcium-binding protein, is associated with myeloid cell differentiation and is expressed in some adenocarcinomas as well as in squamous epithelia and squamous cell carcinoma. In this study, we immunohistochemically investigated S100A9 expression in thyroid neoplasms. S100A9 was absent in normal follicles, follicular adenoma, and follicular and papillary carcinomas with conventional growth structures. In lesions showing a solid, trabecular, or scirrhous growth pattern, S100A9 immunoreacitivity was occasionally observed. One (5.9%) of the 17 follicular carcinomas and three (7.8%) of the 38 papillary carcinomas were regarded as positive for S100A9, but the positive cell areas always accounted for 5% or less. However, S100A9 was positive in all 19 undifferentiated carcinomas examined. Among them, the positive cell area was greater than 5% in 16 (84.2%), and greater than 25% in six (31.6%) cases. It is therefore suggested that S100A4 protein plays an important role in thyroid carcinoma dedifferentiation, and can be considered a novel characteristic of undifferentiated carcinoma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yasuhiro Ito, Kazumori Arai, Ryushi Ryushi, Nozawa Nozawa, Hiroshi Yoshida, Chisato Tomoda, Takashi Uruno, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Kanji Kuma, Kennichi Kakudo, Akira Miyauchi,